Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind Placebo-controlled Study With ASA Treatment in Colorectal Cancer Patients With Mutations in the PI3K Signaling Pathway

NCT02647099 is registered in ClinicalTrials.gov with Anna Martling as lead sponsor.

NCT NCT02647099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02647099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind Placebo-controlled Study With ASA Treatment in Colorectal Cancer Patients With Mutations in the PI3K Signaling Pathway
Lead sponsor
Anna Martling
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 7, 2016
Completion date
August 31, 2026
Enrollment
626 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer